RNS Number:0883O
Celltech Group PLC
29 July 2003

                                  SCHEDULE 10

                   NOTIFICATION OF MAJOR INTERESTS IN SHARES

1. Name of company

Celltech Group plc

2. Name of shareholder having a major interest

Franklin Resources, Inc. and its affiliates including Franklin Mutual Advisers, 
LLC and Templeton Worldwide, Inc. and its affiliates

3. Please state whether notification indicates that it is in respect of holding
of the shareholder named in 2 above or in respect of a non-beneficial interest
or in the case of an individual holder if it is a holding of that person's
spouse or children under the age of 18

As in 2 above

4. Name of the registered holder(s) and, if more than one holder, the number of

shares held by each of them
Bank of New York, London                              144,380
Bank of New York, Europe                              11,230
Chase NA London                                       10,269,986
Citibank NA London                                    39,020
Deutsche Bank AG                                      16,645
Mellon Bank NA                                        542,108
Northern Trust Company                                791,505
Royal Trust Corp of Canada                            190,352
State Street Nominees Limited                         1,846,482

5. Number of shares / amount of stock acquired

N/A

6. Percentage of issued class

N/A

7. Number of shares / amount of stock disposed

2,679,533 (since last notification)

8. Percentage of issued class

0.96%

9. Class of security

Ordinary 50p Shares

10. Date of transaction

Unknown

11. Date company informed

29 July, 2003

12. Total holding following this notification

13,851,708

13. Total percentage holding of issued class following this notification

4.9902%

14. Any additional information

-

15. Name of contact and telephone number for queries

Cheryl Cramer Tel. 01753 447933

16. Name and signature of authorised company official responsible for making
this notification

J A D Slater

Date of notification

29 July, 2003

The FSA does not give any express or implied warranty as to the accuracy of this
document or material and does not accept any liability for error or omission.
The FSA is not liable for any damages (including, without limitation, damages
for loss of business or loss of profits) arising in contract, tort or otherwise
from the use of or inability to use this document, or any material contained in
it, or from any action or decision taken as a result of using this document or
any such material.


                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

HOLEALXNAAFDEFE